MAP3K7 and triple-negative breast carcinoma: After establishing that TAK1 mediates ADAM12 induction by TGF-β in normal human cells, we asked whether it was also involved in the sustained expression of ADAM12 seen in tumor cells, and particularly in Triple-Negative Breast Cancer (TNBC) cells.